Hello world!
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!
IMPORTANT RESEARCH NEWS! PROMISING NEW RESEARCH FUNDED 2022 #defeatmsa #kickmsa #MSAresearch #newresearch #MultipleSystemAtrophy #msaunited #Consortium Help Us – Fund Research Now! Choose A Charity in
We are delighted to hear that Dr Patrik Brundin, a strong advocate for the MSA cause and a dear friend to Defeat MSA Alliance (US)
Defeat MSA Alliance and MSA United International Consortium Celebrates World Rare Disease Day on February 28, 2020 In tribute to all those challenged by multiple
March is our MSA Awareness Month campaign. Please join us this month by “Moving for those who can’t” daily on social media. KICKOFF IS MARCH
HELP DEFEAT MSA! Donate to A Consortium Partner: Defeat MSA Alliance – USA Defeat MSA/Vaincre AMS Canada Defeat MSA Australia and New Zealand, Ltd. (AU-NZ)
HAPPY NEW YEAR!! May this year increase your hope and happiness! Let’s go forward together to Defeat MSA forever! We thank you for your continued
Good Perspective from MSA Warrior & Defeat MSA Canada/Vaincre l’AMS Canada Board Member @Kelly Murphy!
Congratulations to MODAG! On behalf of MSA/AMS patients around the world, we are thankful for your efforts! 💜. https://www.tevapharm.com/news-and-media/latest-news/teva-and-modag-announce-licensing-collaboration-for-neurodegenerative-disease-drug-candidate/
Giving Tuesday is Nov 30; Help Us Defeat MSA Now! Visit Us To Donate: www.DefeatMSA.org/donate-to-us/ THANK YOU – WE CANNOT CONTINUE OUR EFFORTS WITHOUT YOU!
ALTERITY PRESS RELEASE: MELBOURNE, AUSTRALIA AND SAN FRANCISCO, USA – 4 November 2021: Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology
GIVE AWARENESS FOR THE HOLIDAYS! Help Us Defeat MSA Now! USA STORE: https://defeatmsa.org/shop/ CANADA STORE: https://www.msacanada.ca/shop/ AUSTRALIA-NEW ZEALAND STORE: https://www.msadownunder.org.au/shop/ #defeatmsa #KickMSA #awarenessgear #Holidays
Good news from Lundbeck! The company plans to initiate Phase 2 Study for Potential Treatment for Multiple System Atrophy! — Press Release (Mon, Nov 08,
ALTERITY PRESS RELEASE – 19 OCTOBER 2021 Alterity Therapeutics Announces Expanded ATH434 Phase 2 Clinical Development Program – Clinical trial to enroll patients with early-stage
VERY DISAPPOINTING NEWS FROM BIOHAVEN RE: VERDIPERSTAT (& M-STAR STUDY) Biohaven remains committed to neuroscience and to the MSA community. They intend to analyze the
DEFEAT MSA ALLIANCE is pleased to announce the WORLD PREMIERE of a new documentary from New Zealand: “GLIMPSES” on Saturday, Oct 2, 2021 on the
Disappointing News from Theravance in Press Release: —- Theravance Biopharma, Inc. Announces Top-line Results from a Phase 3 Study of Ampreloxetine in Patients with Symptomatic
Keeping Steady – The Redwood Study Visit for more Information: www.redwood-study.com OR https://clinicaltrials.gov/ct2/show/NCT03829657
[et_pb_section fb_built=”1″ admin_label=”section” _builder_version=”3.22″][et_pb_row admin_label=”row” _builder_version=”3.25″ background_size=”initial” background_position=”top_left” background_repeat=”repeat”][et_pb_column type=”4_4″ _builder_version=”3.25″ custom_padding=”|||” custom_padding__hover=”|||”][et_pb_text admin_label=”Text” _builder_version=”4.7.3″ background_size=”initial” background_position=”top_left” background_repeat=”repeat”] The Defeat MSA Alliance Board of Directors
NEWS & VIEWS – June/July Newsletter 2021 Don’t Miss Updates on Research, Support, Education, Awareness & Advocacy! https://mailchi.mp/defeatmsa/junejulynewsletter
Copyright 2022 | Defeat MSA Alliance – 501(c)(3)